Latest News & Features
Americas
Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride). 1 August 2018
Americas
Morgan Lewis & Bockius has boosted its IP litigation team with the addition of seven partners from McDermott Will & Emery who have experience in the life sciences and technology industries. 1 August 2018
Americas
US-based pharmaceutical company Pfizer today reported an increase in year-on-year revenue for the second quarter but projected nearly a $2 billion loss in 2018 due to patent expirations. 31 July 2018
Big Pharma
IP service provider Questel has acquired France-based Expernova, a company specialising in scientific big data. 30 July 2018
Americas
Sandoz has agreed to postpone its generic version of a cataract surgery drug made by biopharmaceutical company Omeros, ending a patent infringement lawsuit between the two in Delaware. 30 July 2018
Biotechnology
A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say. 30 July 2018
Americas
Vanessa Yen has joined King & Spalding's trial and global disputes practice group as a partner after leaving Paul Hastings. 30 July 2018
Americas
Actor Clint Eastwood has gone to war against a medical company which he claims took patents covering an antioxidant from an inventor. 27 July 2018
Americas
GSK revealed its new approach to research and development earlier this week, including a partnership with DNA testing company 23andMe. 27 July 2018
Biotechnology
Genome-editing techniques, including CRISPR/Cas9, will be subject to more stringent regulations after a ruling from Europe’s highest court yesterday. 26 July 2018